| Product Name | MF | CAS | Details |
|---|
| Azidoacetyl-Val-Cit-PAB-OH | C20H30N8O5 | 2285375-34-8 | Details |
| Carlina oxide | C13H10O | 502-22-7 | Details |
| 2-Acetyl-2-decarboxamidotetracycline | C23H25NO8 | 6542-44-5 | Details |
| HH0043 | C23H24F3N5O | 2922069-42-7 | Details |
| HSP90-IN-31 | C22H28N2O4 | 2117645-10-8 | Details |
| Mizoribine prodrug-1 | C19H29N3O8 | 2237237-22-6 | Details |
| Neohesperidose | C12H22O10 | 17074-02-1 | Details |
| H-D-Tyr(Propargyl)-OH | C12H13NO3 | 1170674-20-0 | Details |
| BML-260 | C17H11NO3S2 | 101439-76-3 | Details |
| MMAF-methyl ester | C40H67N5O8 | 2353409-70-6 | Details |
| MFB-1041 | C19H18F2N8OS | 151856-47-2 | Details |
| TLR7 agonist 23 | C21H22N4O2 | 2408268-38-0 | Details |
| MCT-IN-1 | C19H26N2O3 | 1685273-57-7 | Details |
| Thalidomide 5-Pip-C-oxotetrahydropyrimidin-bromophenyl | C29H30BrN5O5 | 3024909-50-7 | Details |
| Hexatriacontane | C36H74 | 630-06-8 | Details |
| 8-MA-cAMP | C11H15N6O6P | 33823-18-6 | Details |
| HDGFRP2/PSIP1-IN-1 | C8H6BrN3 | 166196-54-9 | Details |
| HAC-Y6 | C23H22N2O4 | 1331959-78-4 | Details |
| ALKBH5-IN-2 | C9H11N3O3 | 1008951-10-7 | Details |
| Ethyl palmitoleate | C18H34O2 | 56219-10-4 | Details |
| 8-HA-cAMP | C16H25N6O6P | 59212-44-1 | Details |
| 8-pHPT-2'-O-Me-cAMP | C17H18N5O7PS | 612513-15-2 | Details |
| Norbornene-methyl-NHS | C13H15NO5 | 1986791-87-0 | Details |
| AChE-IN-65 | C15H8N2O6 | 98704-22-4 | Details |
| K284-6111 | C30H37N3O4S | 702668-62-0 | Details |
| Fmoc-D-Lys(pentynoyl)-OH | C26H28N2O5 | 2576508-18-2 | Details |
| Dimesna free acid | C4H10O6S4 | 45127-11-5 | Details |
| PCSK9-IN-31 | C23H26N4O3 | 2247649-76-7 | Details |
| DNA-PK-IN-14 | C20H24N4O3 | 2766001-96-9 | Details |
| AKR1C3-IN-14 | C21H21BrN2O4 | 1057882-82-2 | Details |
| GSK-3β inhibitor 17 | C26H18F3N5O6S2 | 2521624-67-7 | Details |
| GPX4-IN-13 | C23H15NO3 | 2644044-43-7 | Details |
| LEI-800 | C25H24N4O2S | 3040218-10-5 | Details |
| 4-Methoxypyridin-2-amine | C6H8N2O | 10201-73-7 | Details |
| Silicon naphthalocyanine dichloride | C48H24Cl2N8Si | 92396-91-3 | Details |
| KB03-SLF | C50H63ClF3N5O12 | 2384184-42-1 | Details |
| N3-L-Dap(Boc)-OH | 1932432-15-9 | Details |
| Sp-8-Br-cGMPS | C10H11BrN5O6PS | 153660-03-8 | Details |
| Aleniglipron | C49H55FN9O6P | 2685823-26-9 | Details |
| DETD-35 | 1836209-98-3 | Details |
| PROTAC SMARCA2/4-degrader-2 | C52H64N12O6S | 2568277-76-7 | Details |
| ACC1-IN-2 | 3027705-67-2 | Details |
| Fmoc-Abu(3-N3) (2R,3R) | C19H18N4O4 | 1229394-75-5 | Details |
| (S,R,S)-AHPC-C6-PEG3-butyl-N3 | C38H59N7O7S | 2300155-90-0 | Details |
| (2S,4S)-Fmoc-L-Pro(4-NHPoc)-OH | C24H22N2O6 | 2451202-17-6 | Details |
| Aerobactin | C22H36N4O13 | 26198-65-2 | Details |
| PNPLA3 degrader-1 | C16H19ClF2N2O4S | 3036158-98-9 | Details |
| 7β,16α-Dihydroxybufalin | C24H34O6 | 773133-78-1 | Details |
| EPZ-4777 | C27H40N8O4 | 1381761-52-9 | Details |
| 5,6-DM-cBIMP | C14H16N2NaO6P | 142754-31-2 | Details |
| OES2-0017 | C15H34N2 | 5538-95-4 | Details |
| Alloc-Val-Ala-PAB-PNP | C26H30N4O9 | 1884578-27-1 | Details |
| (E)-dodec-2-en-1-ol | C12H24O | 69064-37-5 | Details |
| SD-7300 | C21H30F3N3O7S | 748120-89-0 | Details |
| 8-Br-cAMP-AM | C13H15BrN5O8P | 190522-24-8 | Details |
| Antitumor agent-172 | C37H50N8O4 | 3027905-74-1 | Details |
| GABAA receptor modular-3 | C28H36F2N4O3 | 3021554-08-2 | Details |
| CFTR corrector 16 | C27H26ClN5O2S | 1210305-23-9 | Details |
| Diazido-methyltetrazine tri-arm | C29H43N15O4 | 2861998-18-5 | Details |
| endo CNTinh-03 | C23H25NO5S | 345288-49-5 | Details |
| Isopentyl 3-(4-methoxyphenyl)acrylate | C15H20O3 | 71617-10-2 | Details |
| APE1-IN-3 | C17H16O4 | 1227098-30-7 | Details |
| 8-Hydroxyoctanoic acid-thalidomide | C21H27N3O5 | 2399454-65-8 | Details |
| N3-Gly-Aeg(Fmoc)-OH | 2606227-07-8 | Details |
| EZH2-IN-19 | C40H55N7O3 | 3026848-13-2 | Details |
| SIJ1777 | C26H23F3N8O2 | 839707-55-0 | Details |
| TQ05310 | C19H17F6N7O | 2071196-10-4 | Details |
| E3 Ligase Ligand-linker Conjugate 116 | C48H75N5O15S | 2409844-90-0 | Details |
| PROTAC SMARCA2/4-degrader-7 | C51H61N11O5S | 2568277-89-2 | Details |
| MPO-IN-8 | 62578-87-4 | Details |
| 5'-TMPS | C10H15N2O7PS | 15548-51-3 | Details |
| Primulin | C21H14N3NaO3S3 | 8064-60-6 | Details |
| GSK-J2 sodium | C22H24N5NaO2 | 2108665-15-0 | Details |
| PAWI-2 | C19H21N3O3S | 1448427-02-8 | Details |
| Pentadecanedioic acid | C15H28O4 | 1460-18-0 | Details |
| Sp-8-pCPT-2'-O-Me-cAMPS | C17H17ClN5O5PS2 | 634208-37-0 | Details |
| DAPOA | C5H8N6O3 | 2389064-43-9 | Details |
| (R)-Ketoprofen | C16H14O3 | 56105-81-8 | Details |
| SARS-CoV-2-IN-89 | C17H13FN2O | 1016762-41-6 | Details |
| GPX4-IN-12 | C21H19N5O3 | 931704-14-2 | Details |
| Pentyl decanoate | C15H30O2 | 5933-87-9 | Details |
| DACN(Ms,Ns) | C14H17N3O6S2 | 2411082-25-0 | Details |
| Polyhexamethyleneguanidine hydrochloride | C7H22ClN5 | 57028-96-3 | Details |
| Diphenylacetamide | C14H13NO | 519-87-9 | Details |
| EMD 1204831 | C25H27N7O3 | 1100598-15-9 | Details |
| OG-L002 hydrochloride | C15H16ClNO | 1357299-45-6 | Details |
| KRAS inhibitor-38 | 3059496-10-2 | Details |
| STING antagonist 1 | C31H30FN7 | 3036981-21-9 | Details |
| (2S,3S)-H-Abu(3-N3)-OH hydrochloride | C4H8N4O2.ClH | 2737202-68-3 | Details |
| Tyk2-IN-10 | C25H27N5O3 | 2368945-72-4 | Details |
| TRPV4-IN-5 | C20H22Cl3N3O3S | 3046390-54-6 | Details |
| GLUT1/EGFR-IN-1 | C44H32N4O5 | 2393787-80-7 | Details |
| DA-023 | C20H25N7 | 2585643-97-4 | Details |
| CSF1R-IN-19 | C20H27N7O | 1819989-27-9 | Details |
| AD-8007 | C22H26N2O | 1497439-74-3 | Details |
| Malondialdehyde tetrabutylammonium | C19H39NO2 | 100683-54-3 | Details |
| SDH-IN-18 | C21H21ClN2OSi | 723748-50-3 | Details |
| Boc-D-Lys(N3)-OH | C11H20N4O4 | 1620410-04-9 | Details |
| LY2066948 | C30H31NO5S | 648904-56-7 | Details |
| PRMT5-IN-41 | C22H16F5N5O2 | 3034034-32-4 | Details |
| Product Total： Product Page： | ||||
| 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 | ||||